Asma Ben Abdelkrim
Department of Endocrinology and Diabetology, University Hospital of Farhat Hached, Ibn Jazzar Avenue, 4031 Sousse, Tunisia
Mariam Ghozzi
Department of Immunology, Farhat Hached Hospital University, Ibn Jazzar Avenue, 4031 Sousse, Tunisia; Research Laboratory for "Epidemiology and Immunogenetics of Viral Infections" (LR14SP02), Sahloul University Hospital, University of Sousse, Sousse, Tunisia; Faculty of Pharmacy, Department of Immunology, University of Monastir, Monastir, Tunisia
Ghada Saad
Department of Endocrinology and Diabetology, University Hospital of Farhat Hached, Ibn Jazzar Avenue, 4031 Sousse, Tunisia
Sarra Melayah
Department of Immunology, Farhat Hached Hospital University, Ibn Jazzar Avenue, 4031 Sousse, Tunisia; Faculty of Pharmacy, Department of Immunology, University of Monastir, Monastir, Tunisia; LR12SP11, Biochemistry Department, Sahloul University Hospital, Sousse, Tunisia
Taieb Ach
Department of Endocrinology and Diabetology, University Hospital of Farhat Hached, Ibn Jazzar Avenue, 4031 Sousse, Tunisia
Ibtissem Ghedira
Department of Immunology, Farhat Hached Hospital University, Ibn Jazzar Avenue, 4031 Sousse, Tunisia
Koussay Ach
Department of Endocrinology and Diabetology, University Hospital of Farhat Hached, Ibn Jazzar Avenue, 4031 Sousse, Tunisia
Abstract
Viral infection is known to be a trigger of autoimmune diseases. Numerous cases of coronavirus disease 2019 (COVID-19) with autoimmune manifestations have been reported and several authors have highlighted the relationship between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and autoimmune diseases. Autoimmune myopathies being one of these manifestations. A 27-year-old diabetic woman was admitted for management of acido-ketosis decompensation of her diabetes secondary to SARS-CoV-2 infection. During hospitalization, she developed muscle weakness and increased creatine kinase levels, which led us to assay the autoimmunity pattern which became positive for myositis-specific autoantibodies against single recognition particle (anti-SRP). The patient was treated with intense hydration with clinical and biological improvement and anti-SRP disappeared two months later. Positive myositis auto-antibodies are one of the autoimmune complications that could be seen during and after the SARS-CoV-2 infection.